Header Logo

Connection

Yahya Choonara to Drug Design

This is a "connection" page, showing publications Yahya Choonara has written about Drug Design.
Connection Strength

0,552
  1. Design of an In Situ Cross-Linked Eutectic Tablet for Enhanced Delivery of Gastro-Sensitive Proteins and Peptides. J Pharm Sci. 2016 07; 105(7):2086-98.
    View in: PubMed
    Score: 0,133
  2. Polymeric networks for controlled release of drugs: a patent review. Expert Opin Ther Pat. 2016 Jun; 26(6):703-17.
    View in: PubMed
    Score: 0,132
  3. Disulphide-thiol chemistry: a multi-faceted tool for macromolecular design and synthesis of polyfunctional materials for specialized drug delivery. Curr Drug Deliv. 2015; 12(3):282-98.
    View in: PubMed
    Score: 0,120
  4. Targeted nanotechnologies for cancer intervention: a patent review (2010-2016). Expert Opin Ther Pat. 2017 Sep; 27(9):1005-1019.
    View in: PubMed
    Score: 0,036
  5. Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders. Drug Discov Today. 2016 12; 21(12):1886-1914.
    View in: PubMed
    Score: 0,034
  6. A prospective overview of the essential requirements in molecular modeling for nanomedicine design. Future Med Chem. 2013 May; 5(8):929-46.
    View in: PubMed
    Score: 0,027
  7. The application of a crosslinked pectin-based wafer matrix for gradual buccal drug delivery. J Biomed Mater Res B Appl Biomater. 2012 May; 100(4):1029-43.
    View in: PubMed
    Score: 0,025
  8. Advanced preformulation investigations for the development of a lead intravaginal bioadhesive polymeric device. Drug Dev Ind Pharm. 2012 Mar; 38(3):271-93.
    View in: PubMed
    Score: 0,024
  9. Ocular drug delivery - a look towards nanobioadhesives. Expert Opin Drug Deliv. 2011 Jan; 8(1):71-94.
    View in: PubMed
    Score: 0,023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.